SIBIA Neurosciences (SIBI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SIBIA Neurosciences (SIBI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Frank Stein who wrote (174)	4/26/1998 1:53:00 PM
From: scaram(o)uche	Read Replies (1) of 579

Frank: Thanks, good stuff. Here's a fun article on Pfizer that briefly touches on Aricept and acetyl cholinesterase inhibitors from the Eisai/Pfizer view (the view of those with marketing clout)...... pathfinder.com I was an investor in Athena at the IPO. I still held some of my shares when Elan bought them. Science snobs can let a ton of profit pass by. It will be fun to see what AD therapy looks like long-term, but, thus far, Selkoe/Athena haven't made a buck from AD product sales, while Pfizer, Warner-Lambert and Eisai have. That said, you have realized by now that I was also referring to the BMY program (Abeta, secretase, etc.) when I talked of Alzheimer's and SIBI. Cheers! Rick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next